quinidine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avadhani, NG; Bajpai, P; Bansal, S; Cheng, Q; Chowdhury, G; Fang, JK; Guengerich, FP; Martin, MV; Sangar, MC; Singh, S; Tang, W | 1 |
1 other study(ies) available for quinidine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondrion-targeted cytochrome P450 2D6: implications in Parkinson disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic alpha-Antagonists; Animals; Cell Line; Cytochrome P-450 CYP2D6; Dopamine Agents; Dopaminergic Neurons; Dynamins; Humans; Mice; Mitochondria; Mitochondrial Proteins; Parkinsonian Disorders; Quinidine; Reactive Oxygen Species; Ubiquitin-Protein Ligases | 2013 |